Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

P Kearns; C.M. Zwaan; D Reinhardt; B Gibson; L Moreno; K Nysom; S Nakahara; F Huang; WD Zhou; DA Parasrampuria; S Nemat

doi:10.1111/bjh.15847

Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

P Kearns, C.M. Zwaan, D Reinhardt, B Gibson, L Moreno, K Nysom, S Nakahara, F Huang, WD Zhou, DA Parasrampuria, S Nemat

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E7-E11
Journal	British Journal of Haematology
Volume	186
Issue number	3
DOIs	https://doi.org/10.1111/bjh.15847
Publication status	Published - 2019

Research programs

EMC MM-02-54-03

Access to Document

10.1111/bjh.15847

http://hdl.handle.net/1765/119439

Cite this

Kearns, P., Zwaan, C. M., Reinhardt, D., Gibson, B., Moreno, L., Nysom, K., Nakahara, S., Huang, F., Zhou, WD., Parasrampuria, DA., & Nemat, S. (2019). Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. British Journal of Haematology, 186(3), E7-E11. https://doi.org/10.1111/bjh.15847

@article{6261152f53f242479a8030f57a2af74b,

title = "Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia",

author = "P Kearns and C.M. Zwaan and D Reinhardt and B Gibson and L Moreno and K Nysom and S Nakahara and F Huang and WD Zhou and DA Parasrampuria and S Nemat",

year = "2019",

doi = "10.1111/bjh.15847",

language = "Undefined/Unknown",

volume = "186",

pages = "E7--E11",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

Kearns, P, Zwaan, CM, Reinhardt, D, Gibson, B, Moreno, L, Nysom, K, Nakahara, S, Huang, F, Zhou, WD, Parasrampuria, DA & Nemat, S 2019, 'Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia', British Journal of Haematology, vol. 186, no. 3, pp. E7-E11. https://doi.org/10.1111/bjh.15847

Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. / Kearns, P; Zwaan, C.M.; Reinhardt, D et al.
In: British Journal of Haematology, Vol. 186, No. 3, 2019, p. E7-E11.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

AU - Kearns, P

AU - Zwaan, C.M.

AU - Reinhardt, D

AU - Gibson, B

AU - Moreno, L

AU - Nysom, K

AU - Nakahara, S

AU - Huang, F

AU - Zhou, WD

AU - Parasrampuria, DA

AU - Nemat, S

PY - 2019

Y1 - 2019

U2 - 10.1111/bjh.15847

DO - 10.1111/bjh.15847

M3 - Article

C2 - 30847896

SN - 0007-1048

VL - 186

SP - E7-E11

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -